License: Creative Commons Attribution 4.0 PDF - Published Version (684kB) |
- URN to cite this document:
- urn:nbn:de:bvb:355-epub-589383
- DOI to cite this document:
- 10.5283/epub.58938
Abstract
Abstract Availability of an individualized preselection of oncolytic viruses to be used for virotherapy of tumor patients would be of great help. Using primary liver tumor resection specimens we evaluated the precision-cut liver slice (PCLS) technology as a novel in vitro test system for characterization of paramount tumor infection parameters of individual patients. PCLS slices from resection ...
Owner only: item control page